Free Trial
→ October 16 Changes the Microchip Game — and Investing (From Banyan Hill Publishing) (Ad)tc pixel

ZIVO Bioscience (NASDAQ:ZIVO) Share Price Crosses Above 50-Day Moving Average - Here's What Happened

Written by MarketBeat
Updated August 25, 2025
ZIVO Bioscience logo with Medical background

Key Points

  • ZIVO Bioscience shares have recently exceeded their fifty-day moving average, hitting a high of $19.65 before settling at $18.04 during trading.
  • The company's market capitalization stands at $68.86 million, with a price-to-earnings ratio of -3.70.
  • ZIVO operates in the biotech and agtech sectors, focusing on natural bioactive ingredients derived from proprietary algae cultures.
  • MarketBeat previews top five stocks to own in October.

ZIVO Bioscience, Inc. (NASDAQ:ZIVO - Get Free Report)'s stock price passed above its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of $13.86 and traded as high as $19.65. ZIVO Bioscience shares last traded at $18.04, with a volume of 1,719 shares.

ZIVO Bioscience Price Performance

The stock has a market capitalization of $68.71 million, a price-to-earnings ratio of -3.69 and a beta of -0.06. The business's fifty day moving average price is $14.17 and its 200-day moving average price is $16.25.

About ZIVO Bioscience

(Get Free Report)

ZIVO Bioscience, Inc, a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health.

See Also

Should You Invest $1,000 in ZIVO Bioscience Right Now?

Before you consider ZIVO Bioscience, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ZIVO Bioscience wasn't on the list.

While ZIVO Bioscience currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best Nuclear Energy Stocks to Buy Cover
The Best Nuclear Energy Stocks to Buy

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report
Like this article? Share it with a colleague.